3010 Phase, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): Subgroup analyses and patient reported outcomes (PROs)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Horn, L; Brahmer, J; Reck, M; Borghaei, H; Spigel, DR; Steins, M; Ready, NE; Chow, LQ; Vokes, EE; Felip, E; Holgado, E; Barlesi, F; Kohlhäufl, MJ; Burgio, MA; Fayette, J; Gettinger, SN; Harbison, CT; Li, A; Finckenstein, FG; Paz-Ares, L

Published Date

  • September 2015

Published In

Volume / Issue

  • 51 /

Start / End Page

  • S599 - S599

Published By

International Standard Serial Number (ISSN)

  • 0959-8049

Digital Object Identifier (DOI)

  • 10.1016/s0959-8049(16)31655-0